940 results
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
$11.0 to $12.0 billion
Effective Tax Rate on Adjusted(3) Income
Approximately 15.0%
Adjusted(3) Diluted EPS
$2.15 to $2.35
(previously $2.05 to $2.25 … )/Deductions—net(2)
Effective Tax Rate on Reported(2) Income
* Indicates calculation not meaningful.
First-quarter 2024 Cost of Sales(2
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
political and corporate sustainability priorities, spanning tax policies to issues impacting its workforce. Through aggregate metrics, the report
DEFA14A
PFE
Pfizer Inc.
28 Mar 24
Additional proxy soliciting materials
4:19pm
Section 162(m) under the Tax Cuts and Jobs Act of 2017, and in practice, Pfizer has never granted awards under the prior plans, including the 2019 Plan
S-3ASR
Pfizer Investment Enterprises PTE Ltd
23 Feb 24
Automatic shelf registration
4:34pm
in an accompanying prospectus supplement.
United States federal income tax consequences and special considerations, if any, applicable to any such series … be transferred or exchanged at the designated corporate trust office of the trustee, without the payment of any service charge, other than any tax or other
8-K
EX-99
5b3 hi1iwwhv181
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K/A
rvvmm90
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K/A
EX-99.1
xalm4vpnxmo6qyutgdef
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
EX-99.1
rbjqx2r43sjqd
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
c2q8y274
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
EX-99.1
scziw
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
EX-99.1
lqtg5j
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99
uyfm98v0e2872
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
EX-99
di5l75
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm